✦ LIBER ✦

Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis

✍ Scribed by Andrés Cárdenas; Pere Ginès; Paul Marotta; Frank Czerwiec; John Oyuang; Mónica Guevara; Nezam H Afdhal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Tolvaptan, an Oral Vasopressi

✍ Nicolaos E. Madias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Hyponatremia in Cirrhosis and End-Stage

✍ Paul Gaglio, Kwaku Marfo, Joseph Chiodo III 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 449 KB

Vasopressin V2 Receptor Blockade With To

✍ Mihai Gheorghiade; Stephen S. Gottlieb; James E. Udelson; Marvin A. Konstam; Fra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Short-term Clinical Effects of Tolvaptan

✍ Junichi Oomura; Takeshi Arita; Masakiyo Nobuyoshi; Seiji Iwabuti; Masahiko Gouya 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Nonpeptide vasopressin antagonist and it

✍ Toshikazu Saito; Genro Fujisawa; Yasushi Tsuboi; Koji Okada; San-e Ishikawa 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Non-Peptide Arginine-Vasopressin Antagon

✍ Jeremy D. Fields; Anish Bhardwaj 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 181 KB